USPH (US Physical Therapy Inc) Stock Analysis - Analyst Ratings

US Physical Therapy Inc (USPH) is a publicly traded Healthcare sector company. As of May 20, 2026, USPH trades at $62.16 with a market cap of $989.83M and a P/E ratio of 121.46. USPH moved +0.99% today. Year to date, USPH is -26.12%; over the trailing twelve months it is -21.61%. Its 52-week range spans $58.19 to $101.20. Analyst consensus is strong buy with an average price target of $97.50. Rallies surfaces USPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate USPH?

6 analysts cover USPH: 0 strong buy, 5 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $97.50.

USPH Key Metrics

Key financial metrics for USPH
MetricValue
Price$62.16
Market Cap$989.83M
P/E Ratio121.46
EPS$0.51
Dividend Yield0.46%
52-Week High$101.20
52-Week Low$58.19
Volume184.99K
Avg Volume0
Revenue (TTM)$795.49M
Net Income$52.69M
Gross Margin19.03%

USPH Analyst Consensus

6 analysts cover USPH: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $97.50.

Latest USPH News

Recent USPH Insider Trades

  • REEVE GRAHAM D. sold 662 (~$52.21K) on Mar 11, 2026.
  • REEVE GRAHAM D. sold 1 (~$78.52) on Mar 9, 2026.
  • REEVE GRAHAM D. sold 1.81K (~$148.63K) on Mar 6, 2026.

Common questions about USPH

What do analysts rate USPH?
6 analysts cover USPH: 0 strong buy, 5 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $97.50.
Does Rallies show USPH price targets?
Yes. Rallies tracks USPH analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is USPH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for USPH. It does not provide personalized investment advice.
USPH

USPH